Clinical Trial Update: Teclistamab in Previously Treated AL Amyloidosis [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating teclistamab for previously treated light-chain (AL) amyloidosis is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Light-chain Amyloidosis

Drugs mentioned

• TECVAYLI (TECLISTAMAB-CQYV)

Snippet

Sponsor: Peking Union Medical College Hospital | Conditions: AL Amyloidosis | Phase 2 | Status: RECRUITING